The Royal Wolverhampton Hospitals NHS Trust
2 clinical trials · 2 recruiting · OTHER_GOV
Trials by The Royal Wolverhampton Hospitals NHS Trust
RECRUITINGNCT04234022
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
The outlook for patients with haematological malignancies remains challenging. It has been shown in some early cancer studies that a particular drug called Zn-DDC otherwise known...
Sponsor: The Royal Wolverhampton Hospitals NHS TrustEnrolling: 701 location
Multiple Myeloma
RECRUITINGNCT04741230
Investigator Initiated, Prospective Study of Xenia Corneal Lenticule
Cornea ectatic conditions such as keratoconus and post-LASIK (Laser In situ Keratomileusis) ectasia are disorders of the eye that are notorious for its uncontrolled progression...
Sponsor: The Royal Wolverhampton Hospitals NHS TrustEnrolling: 151 location
KeratoconusPost-Laser Retinal Condition